Your browser has javascript turned off or blocked. This will lead to some parts of our website to not work properly or at all. Turn on javascript for best performance.

The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Tanja Stocks

Tanja Stocks

Researcher

Tanja Stocks

Serum triglycerides and cancer risk in the metabolic syndrome and cancer (Me-Can) collaborative study

Author

  • Wegene Borena
  • Tanja Stocks
  • Hakan Jonsson
  • Susanne Strohmaier
  • Gabriele Nagel
  • Tone Bjorge
  • Jonas Manjer
  • Goeran Hallmans
  • Randi Selmer
  • Martin Almquist
  • Christel Haggstrom
  • Anders Engeland
  • Steinar Tretli
  • Hans Concin
  • Alexander Strasak
  • Paer Stattin
  • Hanno Ulmer

Summary, in English

To assess the association between serum triglyceride levels and cancer risk. The metabolic syndrome and cancer project (Me-Can) includes cohorts from Norway, Austria, and Sweden; the current study included data on 257,585 men and 256,512 women. The mean age at study entry was 43.8 years for men and 44.2 years for women. The mean follow-up time was 13.4 years (SD = 8.5) for men and 11.9 years (SD = 7.2) for women. Excluding the first year of follow-up, 23,060 men and 15,686 women were diagnosed with cancer. Cox regression models were used to calculate relative risk (RR) of cancer for triglyceride levels in quintiles and as a continuous variable. RRs were corrected for random error by use of regression dilution ratio. Relative risk for top quintile versus bottom quintile of triglycerides of overall cancer was 1.16 (95% confidence interval 1.06-1.26) in men and 1.15 (1.05-1.27) in women. For specific cancers, significant increases for top quintile versus bottom quintile of triglycerides among men were found for cancers of the colon, respiratory tract, the kidney, melanoma and thyroid and among women, for respiratory, cervical, and non-melanoma skin cancers. Data from our study provided evidence for a possible role of serum triglycerides in cancer development.

Department/s

  • EpiHealth: Epidemiology for Health
  • Surgery

Publishing year

2011

Language

English

Pages

291-299

Publication/Series

Cancer Causes and Control

Volume

22

Issue

2

Document type

Journal article

Publisher

Springer

Topic

  • Cancer and Oncology

Keywords

  • Lipids
  • Prospective study
  • Cancer incidence

Status

Published

Research group

  • Surgery

ISBN/ISSN/Other

  • ISSN: 1573-7225